Our client is a US-based, oncology-focused CRO that partnered with BioTalent to build its Radioligand Therapy (RLT) function from the ground up. With RLT emerging as a cutting-edge field but lacking in experienced talent, the client needed a strategic hiring partner to help them establish credibility and capability in this highly specialised space.
Radioligand therapy represents one of the most promising but complex frontiers in oncology. For this CRO, entering the RLT space was a strategic move to deepen specialisation and open new market opportunities. However, without existing infrastructure or access to experienced RLT professionals, the client faced:
BioTalent designed and delivered a tailored talent acquisition strategy focused entirely on RLT and radiopharmaceutical development.
We began by leveraging our expert networks to identify candidates with deep experience in nuclear medicine, radiochemistry, theranostics, and complex oncology operations. Despite the scarcity, we successfully placed key hires including three Clinical Project Managers, a CMC consultant, multiple CRAs, and other functional experts, each selected for their domain expertise and cultural alignment.
Our partnership has continued beyond initial hires, with pipeline development and workforce planning ensuring the client can scale sustainably as demand for RLT expertise grows.
“Building a specialist function from scratch?
Get in touch below with the BioTalent team.